eNauka - pregled

Pregled prema Autor Svorcan, Petar V

Prikaz rezultata 1 do 18 od 18
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2024Anemia in Inflammatory Bowel Diseases Treated by Liposomal IronMarkovic, Srdjan; Kralj, Djordje; Knezevic-Ivanovski, Tamara; Mitrovic, Milos; Odanovic, Olga; Brzacki, Vesna M; Svorcan, Petar VNaučni članak
22M22 - Međunarodni časopis kategorije M22
2019Association of PNPLA3 and TM6SF2 variants with alcoholic liver cirrhosis in Serbian populationNesic, B; Grubisa, Ivana I  ; Djordjevic, Jelena; Vrinic-Kalem, Dusica; Svorcan, Petar VKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD ServiceMarkovic, Srdjan T; Knezevic-Ivanovski, Tamara; Zogovic, Branimir; Cvetkovic, Mirjana; Svorcan, Petar VInformativni prilog
21M21 - Vodeći međunarodni časopis kategorije M21
2024Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective StudyKnezevic, Tamara; Dobrosavljevic, A; Odanovic, O; Sreckovic, S; Kralj, Djordje; Mitrovic, M; Svorcan, Petar V; Markovic, SKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2025Disease Clearence after Acute Severe Ulcerative Colitis episode: is it possible ?Markovic, Srdjan T; Kralj, Djordje; Mitrovic, M; Knezevic-Ivanovski, Tamara; Kalaba, Ana; Odanovic, Olga; Maksimovic, B; Sreckovic, Slobodan; Svorcan, Petar VKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Faecal calprotecin may be a good predictor of histologic remission in ulcerative colitisKnezevic-Ivanovski, Tamara; Knezevic-Usaj, Slavica F; Svorcan, Petar V; Nedeljkovic-Protic, Marijana BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2017Fecal calprotectin as suitable biomarker in evaluation of histological disease activityKnezevic-Ivanovski, Tamara; Knezevic-Usaj, Slavica F; Gligorijevic, Vladimir; Markovic, Srdjan T; Svorcan, Petar V; Nedeljkovic-Protic, Marijana BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccinationKnezevic, Tamara; Cujic, Danica  ; Odanovic, O; Kralj, D; Gnjatovic, Marija Lj  ; Kalaba, Ana; Vrinic-Kalem, Dusica; Svorcan, Petar V; Markovic, SKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2025Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective StudyKnezevic-Ivanovski, Tamara; Milic-Perovic, Marija; Stopic, Bojan; Golubovic, Olga; Kralj, Djordje; Mitrovic, Milos; Sreckovic, Slobodan; Dobrosavljevic, Ana; Svorcan, Petar V; Markovic, Srdjan TNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2020Is mucosal healing sufficient paramater for anti-TNF discontinuation?Knezevic, Tamara; Milic, M; Kalaba, Ana; Sreckovic, S; Stopic, Bojan; Svorcan, Petar V; Markovic, Srdjan TKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2007Is there such thing as "reversible dementia" (RD)?Milosevic, Dragoslav P; Kostic, Svetlana I; Potic, Bojana D; Kalasic, A; Svorcan, Petar V; Bojic, Daniela Z; Erceg, Predrag  ; Davidovic, Mladen MNaučni članak
22M22 - Međunarodni časopis kategorije M22
2003Lidocaine metabolite - monoethyl-glycinexylidide (MEGX) as a quantitative test of hepatic function in patients with hepatic tumours: Comparation with the routine liver functional testsSvorcan, Petar V; Stankovic, Sanja Dj  ; Bojic, A; Colic, N; Dapcevic, Branka D; Ilic, Mirka N; Radovic, B; Majkic-Singh, Nada TKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2000Mechanism of diarrhea in microscopic colitis.Nedeljkovic-Protic, Marijana B; Necic, D; Djuric, SM; Jojic, Njegica Z; Svorcan, Petar V; Dapcevic, Branka D; Popovic, OKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Quality of life of patients with inflammatory bowel diseases in remission on different forms of treatmentKalaba, Ana; Markovic, M; Jankovic, M; Zaric, Dusan; Markovic, Srdjan T; Svorcan, Petar VKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2024Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's DiseaseGraham, David Y; ...; Svorcan, Petar V; ...; (broj, koautora 17)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2025Telehealth-An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel DiseaseMarkovic, Srdjan T; Kralj, Djordje; Knezevic-Ivanovski, Tamara; Svorcan, Petar VNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2023The effect of antiTNF alpha and anti-integrin agents on liver steatosis in inlamatory bowel disease patients with non-alcoholic fatty liver diseaseMitrovic, M; Markovic, Srdjan T; Kalaba, Ana; Zaric, Dusan; Kralj, D; Milic, A; Svorcan, Petar VKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2024The potential role of artificial intelligence in selecting the modality of biological therapy in patients with inflammatory bowel diseaseMitrovic, M; Milic, A; Markovic, S; Svorcan, Petar VKonferencijski rad
Mp kategorija će biti prikazana naknadno.